Study Comparing the Safety of ASP2151 to Valacyclovir and Placebo in Healthy Volunteers

NCT00870441 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

442

Enrollment

INDUSTRY

Sponsor class

Stopped Study terminated due to treatment-emergent serious adverse events

Conditions

Safety of ASP2151

Interventions

DRUG: ASP2151
DRUG: Valacyclovir
DRUG: Placebo

Sponsor

Astellas Pharma Inc